Prelude therapeutics to participate in citizens life sciences conference

Wilmington, del., may 01, 2025 (globe newswire) -- prelude therapeutics incorporated (prelude) (nasdaq: prld), a clinical-stage precision oncology company, announced today that the company will participate in the citizens life sciences conference taking place in new york on may 7, 2025.

PRLD Ratings Summary

PRLD Quant Ranking